Buy now! Experts say 8 stocks to see 22-130% Q1 profit growth

Buy now! Experts say 8 stocks to see 22-130% Q1 profit growth
  • Language
  • App
  • Subscriptions
  • Specials
  • Sign-In
  • Register
GeStepAhead GrowMyMoney IThe Winning Leap SME Special
Moneycontrol
Buy now! Experts say 8 stocks to see 22-130% Q1 profit growth
  • 
	Next week India Inc kickstarts April-June earnings season of FY14. Brokerages are warning that the upcoming earnings season, which begins on the July 10 with IndusInd Bank's numbers, will not lay the groundwork for a blockbuster recovery as the year goes on.

	Despite all that talk of taking steps to spur growth, boost investment, and get back on the high growth path, the UPA government may not have much to show as corporate earnings go. Experts say a depreciating rupee and global uncertainities have set the tone for a sluggish quarter to follow two consecutive quarters of near-zero growth.

	However, Angel Broking cherry picks 8 stocks that you can buy now. According to the firm, these companies are likely to fetch 22-130% profit growth in April-June period.

	Check out the stocks…

    Next week India Inc kickstarts April-June earnings season of FY14. Brokerages are warning that the upcoming earnings season, which begins on the July 10 with IndusInd Bank's numbers, will not lay the groundwork for a blockbuster recovery as the year goes on. Despite all that talk of taking steps to spur growth, boost investment, and get back on the high growth path, the UPA government may not have much to show as corporate earnings go. Experts say a depreciating rupee and global uncertainities have set the tone for a sluggish quarter to follow two consecutive quarters of near-zero growth. However, Angel Broking cherry picks 8 stocks that you can buy now. According to the firm, these companies are likely to fetch 22-130% profit growth in April-June period. Check out the stocks…

  • 
	Aurobindo Pharma

	Q1FY14 Profit (estimates): Rs 182 crore

	YoY jump (estimates): 130.4%

	Target: Rs 271

	Rating: BUY

	Rationale: Aurobindo Pharma is expected to post a net sales growth of 38.7% YoY. The margins are likely to expand to 16.2% vs 10.3% in 1QFY2014, which will lead the net profit of Rs 182cr vs Rs 79cr in 1QFY2014.

    Aurobindo Pharma Q1FY14 Profit (estimates): Rs 182 crore YoY jump (estimates): 130.4% Target: Rs 271 Rating: BUY Rationale: Aurobindo Pharma is expected to post a net sales growth of 38.7% YoY. The margins are likely to expand to 16.2% vs 10.3% in 1QFY2014, which will lead the net profit of Rs 182cr vs Rs 79cr in 1QFY2014.

  • 
	Maruti Suzuki

	Q1FY14 Profit (estimates):  : Rs 785 crore

	YoY jump (estimates): 85.2%

	Target: Rs 1822

	Rating: BUY

	Rationale: It reported around10% YoY decline in volumes in 1QFY2014 on account of a slowdown in petrol and diesel car sales and also due to decline in exports. However, with a 10% YoY growth in net average realisation, due to superior product-mix and price increases, it expects only a marginal decline of around1% in the top-line (excluding Suzuki Power Train operations).

    Maruti Suzuki Q1FY14 Profit (estimates):  : Rs 785 crore YoY jump (estimates): 85.2% Target: Rs 1822 Rating: BUY Rationale: It reported around10% YoY decline in volumes in 1QFY2014 on account of a slowdown in petrol and diesel car sales and also due to decline in exports. However, with a 10% YoY growth in net average realisation, due to superior product-mix and price increases, it expects only a marginal decline of around1% in the top-line (excluding Suzuki Power Train operations).

  • 
	Bharti Airtel

	Q1FY14 Profit (estimates):  : Rs 784 crore

	YoY jump (estimates): 54.2%

	Target: Rs 321

	Rating: ACCUMULATE

	Rationale: With rupee testing 60/USD telecom firms which have foreign currency debt exposure areset to be hurt by the ongoing slide in the rupee but Bharti is better placed as it is repaying its debt from the cash flows of African operation. In Africa, a majority of Bharti's revenue comes from Nigerian geography, the currency of which (Nigerian naira - NGN) has in fact appreciated in the last three months. So Bharti is not expected to undergo any negative impact due to the rupee's sharp depreciation. Due to translation of accounts into rupee denomination, the company might see translation losses on the interest repayments front but it will not incur any economic losses.
	 

    Bharti Airtel Q1FY14 Profit (estimates):  : Rs 784 crore YoY jump (estimates): 54.2% Target: Rs 321 Rating: ACCUMULATE Rationale: With rupee testing 60/USD telecom firms which have foreign currency debt exposure areset to be hurt by the ongoing slide in the rupee but Bharti is better placed as it is repaying its debt from the cash flows of African operation. In Africa, a majority of Bharti's revenue comes from Nigerian geography, the currency of which (Nigerian naira - NGN) has in fact appreciated in the last three months. So Bharti is not expected to undergo any negative impact due to the rupee's sharp depreciation. Due to translation of accounts into rupee denomination, the company might see translation losses on the interest repayments front but it will not incur any economic losses.  

  • 
	Indoco Remedies

	Q1FY14 Profit (estimates):  Rs 14.4 crore

	YoY jump (estimates): 39.1%

	Target: Rs 78

	Rating: BUY

	Rationale: Indoco Remedies is expected to report a top-line growth of 20.8% to Rs 183cr.The OPM is expected to expand by 10bp YoY to 13.8%. As a result, the net profit is expected to increase by 39.1% YoY to Rs 14.4 crore.

    Indoco Remedies Q1FY14 Profit (estimates):  Rs 14.4 crore YoY jump (estimates): 39.1% Target: Rs 78 Rating: BUY Rationale: Indoco Remedies is expected to report a top-line growth of 20.8% to Rs 183cr.The OPM is expected to expand by 10bp YoY to 13.8%. As a result, the net profit is expected to increase by 39.1% YoY to Rs 14.4 crore.

  • 
	Lupin

	Q1FY14 Profit (estimates): Rs 367.3 crore

	YoY jump (estimates): 31%

	Target: Rs 877

	Rating: ACCUMULATE

	Rationale: Lupin is expected to register a strong revenue growth of 31.1%. Its OPM is expected to expand by 220bps during the period, on account of which, the net profit will increase by around 31% for the quarter.

    Lupin Q1FY14 Profit (estimates): Rs 367.3 crore YoY jump (estimates): 31% Target: Rs 877 Rating: ACCUMULATE Rationale: Lupin is expected to register a strong revenue growth of 31.1%. Its OPM is expected to expand by 220bps during the period, on account of which, the net profit will increase by around 31% for the quarter.

  • 
	DB Corp

	Q1FY14 Profit (estimates):  :  28.1%

	YoY jump (estimates): Rs 52 crore

	Target: Rs 290

	Rating: BUY

	Rationale: The underperformance of print media stocks can be attributed to OPM pressure on account of losses in emerging editions, higher newsprint costs and cyclical nature of ad revenue growth (sluggish due to slower GDP growth). Due to these cyclical headwinds, stocks are currently trading at relatively cheaper valuations. However, considering the structural positives of the print business (high brand loyalty and significant entry barriers) and reduction in losses of emerging editions, print media stocks deserve a premium to the Sensex.
	 

    DB Corp Q1FY14 Profit (estimates):  :  28.1% YoY jump (estimates): Rs 52 crore Target: Rs 290 Rating: BUY Rationale: The underperformance of print media stocks can be attributed to OPM pressure on account of losses in emerging editions, higher newsprint costs and cyclical nature of ad revenue growth (sluggish due to slower GDP growth). Due to these cyclical headwinds, stocks are currently trading at relatively cheaper valuations. However, considering the structural positives of the print business (high brand loyalty and significant entry barriers) and reduction in losses of emerging editions, print media stocks deserve a premium to the Sensex.  

  • 
	KPIT Cummins

	Q1FY14 Profit (estimates): Rs 63 crore

	QoQ jump (estimates): 22.5%

	Target: Rs 144

	Rating: BUY

	Rationale: The profitability is expected to go up around 22% QoQ  to Rs 63 crore on the back of higher other income QoQ and rupee depreciation coupled with decent volume growth.
	 

    KPIT Cummins Q1FY14 Profit (estimates): Rs 63 crore QoQ jump (estimates): 22.5% Target: Rs 144 Rating: BUY Rationale: The profitability is expected to go up around 22% QoQ  to Rs 63 crore on the back of higher other income QoQ and rupee depreciation coupled with decent volume growth.  

  • 
	Cadila

	Q1FY14 Profit (estimates): Rs 237.1 crore

	YoY jump (estimates): 21.7%

	Target: Rs 929

	Rating: BUY

	Rationale: Cadila is expected to post yet another strong quarter with a 20.1% growth in net sales to Rs 1,820cr, on the back of robustgrowth on the exports front. On the OPM front, we expect the company's OPM to dip by 190bp YoY to 15.7%. The net profit is expected to grow by 21.7% yoy to Rs 237 crore, on back of higher tax outgo.
	 

    Cadila Q1FY14 Profit (estimates): Rs 237.1 crore YoY jump (estimates): 21.7% Target: Rs 929 Rating: BUY Rationale: Cadila is expected to post yet another strong quarter with a 20.1% growth in net sales to Rs 1,820cr, on the back of robustgrowth on the exports front. On the OPM front, we expect the company's OPM to dip by 190bp YoY to 15.7%. The net profit is expected to grow by 21.7% yoy to Rs 237 crore, on back of higher tax outgo.  

  • 
	Next week India Inc kickstarts April-June earnings season of FY14. Brokerages are warning that the upcoming earnings season, which begins on the July 10 with IndusInd Bank's numbers, will not lay the groundwork for a blockbuster recovery as the year goes on.

	Despite all that talk of taking steps to spur growth, boost investment, and get back on the high growth path, the UPA government may not have much to show as corporate earnings go. Experts say a depreciating rupee and global uncertainities have set the tone for a sluggish quarter to follow two consecutive quarters of near-zero growth.

	However, Angel Broking cherry picks 8 stocks that you can buy now. According to the firm, these companies are likely to fetch 22-130% profit growth in April-June period.

	Check out the stocks…
  • 
	Aurobindo Pharma

	Q1FY14 Profit (estimates): Rs 182 crore

	YoY jump (estimates): 130.4%

	Target: Rs 271

	Rating: BUY

	Rationale: Aurobindo Pharma is expected to post a net sales growth of 38.7% YoY. The margins are likely to expand to 16.2% vs 10.3% in 1QFY2014, which will lead the net profit of Rs 182cr vs Rs 79cr in 1QFY2014.
  • 
	Maruti Suzuki

	Q1FY14 Profit (estimates):  : Rs 785 crore

	YoY jump (estimates): 85.2%

	Target: Rs 1822

	Rating: BUY

	Rationale: It reported around10% YoY decline in volumes in 1QFY2014 on account of a slowdown in petrol and diesel car sales and also due to decline in exports. However, with a 10% YoY growth in net average realisation, due to superior product-mix and price increases, it expects only a marginal decline of around1% in the top-line (excluding Suzuki Power Train operations).
  • 
	Bharti Airtel

	Q1FY14 Profit (estimates):  : Rs 784 crore

	YoY jump (estimates): 54.2%

	Target: Rs 321

	Rating: ACCUMULATE

	Rationale: With rupee testing 60/USD telecom firms which have foreign currency debt exposure areset to be hurt by the ongoing slide in the rupee but Bharti is better placed as it is repaying its debt from the cash flows of African operation. In Africa, a majority of Bharti's revenue comes from Nigerian geography, the currency of which (Nigerian naira - NGN) has in fact appreciated in the last three months. So Bharti is not expected to undergo any negative impact due to the rupee's sharp depreciation. Due to translation of accounts into rupee denomination, the company might see translation losses on the interest repayments front but it will not incur any economic losses.
	 
  • 
	Indoco Remedies

	Q1FY14 Profit (estimates):  Rs 14.4 crore

	YoY jump (estimates): 39.1%

	Target: Rs 78

	Rating: BUY

	Rationale: Indoco Remedies is expected to report a top-line growth of 20.8% to Rs 183cr.The OPM is expected to expand by 10bp YoY to 13.8%. As a result, the net profit is expected to increase by 39.1% YoY to Rs 14.4 crore.
  • 
	Lupin

	Q1FY14 Profit (estimates): Rs 367.3 crore

	YoY jump (estimates): 31%

	Target: Rs 877

	Rating: ACCUMULATE

	Rationale: Lupin is expected to register a strong revenue growth of 31.1%. Its OPM is expected to expand by 220bps during the period, on account of which, the net profit will increase by around 31% for the quarter.
  • 
	DB Corp

	Q1FY14 Profit (estimates):  :  28.1%

	YoY jump (estimates): Rs 52 crore

	Target: Rs 290

	Rating: BUY

	Rationale: The underperformance of print media stocks can be attributed to OPM pressure on account of losses in emerging editions, higher newsprint costs and cyclical nature of ad revenue growth (sluggish due to slower GDP growth). Due to these cyclical headwinds, stocks are currently trading at relatively cheaper valuations. However, considering the structural positives of the print business (high brand loyalty and significant entry barriers) and reduction in losses of emerging editions, print media stocks deserve a premium to the Sensex.
	 
  • 
	KPIT Cummins

	Q1FY14 Profit (estimates): Rs 63 crore

	QoQ jump (estimates): 22.5%

	Target: Rs 144

	Rating: BUY

	Rationale: The profitability is expected to go up around 22% QoQ  to Rs 63 crore on the back of higher other income QoQ and rupee depreciation coupled with decent volume growth.
	 
  • 
	Cadila

	Q1FY14 Profit (estimates): Rs 237.1 crore

	YoY jump (estimates): 21.7%

	Target: Rs 929

	Rating: BUY

	Rationale: Cadila is expected to post yet another strong quarter with a 20.1% growth in net sales to Rs 1,820cr, on the back of robustgrowth on the exports front. On the OPM front, we expect the company's OPM to dip by 190bp YoY to 15.7%. The net profit is expected to grow by 21.7% yoy to Rs 237 crore, on back of higher tax outgo.
	 

Get started using your favorite social network

or

Login using moneycontrol ID

Username
Password

Need help logging in? Reset password.

Don´t have an account? Sign Up

Get started using your favorite social network

or

Simply sign up using this short form

* mandatory

UserName*

Username should be atleast 4 character

Password*

Password should be 8 or more characters,
atleast 1 number, 1 symbol & 1 upper case letter

Alert

Your Password should contain
  • 8 or more characters
  • At least 1 number
  • At least 1 symbol
  • At least 1 upper case letter
Confirm Password*
Email
Already have an account? Login